SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000908733-07-000025
Filing Date
2007-01-08
Accepted
2007-01-08 14:38:50
Documents
1

Document Format Files

Seq Description Document Type Size
1 LA JOLLA PHARMACEUTICALS CO 13GA2 lajollapharmaceuticals.htm SC 13G/A 9581
  Complete submission text file 0000908733-07-000025.txt   11821
Mailing Address 227 W MONROE ST STE 3000 CHICAGO IL 60606
Business Address 227 W MONROE STREET SUITE 3000 CHICAGO IL 60606 3126349231
COLUMBIA WANGER ASSET MANAGEMENT LP (Filed by) CIK: 0000908733 (see all company filings)

IRS No.: 363820584 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000

Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Subject) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-44849 | Film No.: 07517198
SIC: 2836 Biological Products, (No Diagnostic Substances)